PIK3CA and breast cancer: The wild-type breast cancer cell lines transfected with constitutively oncogenic PIK3CA mutations showed almost insensitive toward trastuzumab, suggesting the major role of PIK3CA in the development of resistance to trastuzumab (Berns et al., 2007).